Biblio

Found 133 results
Author Keyword Title Type [ Year(Asc)]
2020
Zhang W, Tarutani A, Newell KL, Murzin AG, Matsubara T, Falcon B, Vidal R, Garringer HJ, Shi Y, Ikeuchi T et al..  2020.  Novel tau filament fold in corticobasal degeneration.. Nature. 580(7802):283-287.
Curtis D, Bakaya K, Sharma L, Bandyopadhyay S.  2020.  Weighted burden analysis of exome-sequenced late-onset Alzheimer's cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways.. Ann Hum Genet. 84(3):291-302.
2019
Sekar S, Liang WS.  2019.  Circular RNA expression and function in the brain.. Noncoding RNA Res. 4(1):23-29.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, Boland A, Vronskaya M, van der Lee SJ, Amlie-Wolf A et al..  2019.  Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet. 51(3):414-430.
Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, Li Z, Del-Aguila JL, Dube U, Farias FGeraldo et al..  2019.  The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.. Sci Transl Med. 11(505)
Del-Aguila JL, Benitez BA, Li Z, Dube U, Mihindukulasuriya KA, Budde JP, Farias FHG, Fernández MVictoria, Ibañez L, Jiang S et al..  2019.  TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers.. Mol Neurodegener. 14(1):18.
2018
Nafikov RA, Nato AQ, Sohi H, Wang B, Brown L, Horimoto AR, Vardarajan BN, Barral SM, Tosto G, Mayeux RP et al..  2018.  Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP.. Genet Epidemiol. 42(6):500-515.
Lee S, Zhou X, Gao Y, Vardarajan B, Reyes-Dumeyer D, Rajan KB, Wilson RS, Evans DA, Besser LM, Kukull WA et al..  2018.  Episodic memory performance in a multi-ethnic longitudinal study of 13,037 elderly.. PLoS One. 13(11):e0206803.
Butkiewicz M, Blue EE, Leung YYee, Jian X, Marcora E, Renton AE, Kuzma A, San Wang L-, Koboldt DC, Haines JL et al..  2018.  Functional annotation of genomic variants in studies of late-onset Alzheimer's disease.. Bioinformatics. 34(16):2724-2731.
DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, Sims R, Foroud T, Hernandez I, Moreno-Grau S et al..  2018.  Genetic risk for schizophrenia and psychosis in Alzheimer disease.. Mol Psychiatry. 23(4):963-972.
Li Z, Del-Aguila JL, Dube U, Budde J, Martinez R, Black K, Xiao Q, Cairns NJ, Dougherty JD, Lee J-M et al..  2018.  Genetic variants associated with Alzheimer's disease confer different cerebral cortex cell-type population structure.. Genome Med. 10(1):43.
Blue EE, Bis JC, Dorschner MO, Tsuang DW, Barral SM, Beecham G, Below JE, Bush WS, Butkiewicz M, Cruchaga C et al..  2018.  Genetic Variation in Genes Underlying Diverse Dementias May Explain a Small Proportion of Cases in the Alzheimer's Disease Sequencing Project.. Dement Geriatr Cogn Disord. 45(1-2):1-17.
Gao S, Casey AE, Sargeant TJ, Mäkinen V-P.  2018.  Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.. Brain. 141(9):2711-2720.
Broce I, Karch CM, Wen N, Fan CC, Wang Y, Tan CHong, Kouri N, Ross OA, Höglinger GU, Müller U et al..  2018.  Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.. PLoS Med. 15(1):e1002487.
Wang M, Beckmann ND, Roussos P, Wang E, Zhou X, Wang Q, Ming C, Neff R, Ma W, Fullard JF et al..  2018.  The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease.. Sci Data. 5:180185.
Naj AC, Lin H, Vardarajan BN, White S, Lancour D, Ma Y, Schmidt M, Sun F, Butkiewicz M, Bush WS et al..  2018.  Quality control and integration of genotypes from two calling pipelines for whole genome sequence data in the Alzheimer's disease sequencing project.. Genomics.
Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, Salerno WJ, Lancour D, Ma Y, Renton AE et al..  2018.  Whole exome sequencing study identifies novel rare and common Alzheimer's-Associated variants involved in immune response and transcriptional regulation.. Mol Psychiatry.
Vardarajan BN, Barral S, Jaworski J, Beecham GW, Blue E, Tosto G, Reyes-Dumeyer D, Medrano M, Lantigua R, Naj A et al..  2018.  Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease.. Ann Clin Transl Neurol. 5(4):406-417.
Raghavan NS, Brickman AM, Andrews H, Manly JJ, Schupf N, Lantigua R, Wolock CJ, Kamalakaran S, Petrovski S, Tosto G et al..  2018.  Whole-exome sequencing in 20,197 persons for rare variants in Alzheimer's disease.. Ann Clin Transl Neurol. 5(7):832-842.
2017
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
Beecham GW, Bis JC, Martin ER, Choi S-H, Destefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Mastroeni D, Sekar S, Nolz J, Delvaux E, Lunnon K, Mill J, Liang WS, Coleman PD.  2017.  ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.. PLoS One. 12(7):e0177814.
Huang K-L, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SChih, Harari O, Bertelsen S, Fairfax BP, Czajkowski J et al..  2017.  A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.. Nat Neurosci. 20(8):1052-1061.
Desikan RS, Fan CChieh, Wang Y, Schork AJ, Cabral HJ, L Cupples A, Thompson WK, Besser L, Kukull WA, Holland D et al..  2017.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.. PLoS Med. 14(3):e1002258.